- Home
- DTIL vs AIXI Comparison
DTIL vs AIXI Comparison
Compare DTIL & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- AIXI
- Stock Information
- Founded
- DTIL 2006
- AIXI 2001
- Country
- DTIL United States
- AIXI China
- Employees
- DTIL N/A
- AIXI N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- DTIL Health Care
- AIXI Technology
- Exchange
- DTIL Nasdaq
- AIXI Nasdaq
- Market Cap
- DTIL 43.3M
- AIXI 43.9M
- IPO Year
- DTIL 2019
- AIXI 2023
- Fundamental
- Price
- DTIL $5.55
- AIXI $3.61
- Analyst Decision
- DTIL Strong Buy
- AIXI
- Analyst Count
- DTIL 3
- AIXI 0
- Target Price
- DTIL $37.67
- AIXI N/A
- AVG Volume (30 Days)
- DTIL 196.7K
- AIXI 100.1K
- Earning Date
- DTIL 05-12-2025
- AIXI 05-06-2025
- Dividend Yield
- DTIL N/A
- AIXI N/A
- EPS Growth
- DTIL N/A
- AIXI N/A
- EPS
- DTIL 1.04
- AIXI N/A
- Revenue
- DTIL $68,696,000.00
- AIXI $65,643,604.00
- Revenue This Year
- DTIL N/A
- AIXI $22.85
- Revenue Next Year
- DTIL $30.20
- AIXI $22.70
- P/E Ratio
- DTIL $5.34
- AIXI N/A
- Revenue Growth
- DTIL 40.98
- AIXI 6.22
- 52 Week Low
- DTIL $3.61
- AIXI $2.06
- 52 Week High
- DTIL $13.44
- AIXI $16.08
- Technical
- Relative Strength Index (RSI)
- DTIL 59.70
- AIXI 48.83
- Support Level
- DTIL $4.90
- AIXI $2.52
- Resistance Level
- DTIL $5.75
- AIXI $3.60
- Average True Range (ATR)
- DTIL 0.35
- AIXI 0.46
- MACD
- DTIL 0.13
- AIXI 0.10
- Stochastic Oscillator
- DTIL 88.49
- AIXI 68.61
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.